[Prognostic value of the LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis) in soft tissue infections: a prospective study at Clermont-Ferrand University hospital].
Identifieur interne : 002B82 ( PubMed/Curation ); précédent : 002B81; suivant : 002B83[Prognostic value of the LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis) in soft tissue infections: a prospective study at Clermont-Ferrand University hospital].
Auteurs : V. Corbin [France] ; M. Vidal ; J. Beytout ; H. Laurichesse ; M. D'Incan ; P. Souteyrand ; O. LesensSource :
- Annales de dermatologie et de venereologie [ 0151-9638 ] ; 2010.
Descripteurs français
- KwdFr :
- Abcès (étiologie), Adulte, Adulte d'âge moyen, Antibactériens (usage thérapeutique), Bactériémie (), Choc septique (épidémiologie), Choc septique (étiologie), Diagnostic précoce, Débridement, Fasciite nécrosante (), Fasciite nécrosante (diagnostic), Fasciite nécrosante (sang), Fasciite nécrosante (traitement médicamenteux), Fasciite nécrosante (épidémiologie), Fasciite nécrosante (étiologie), Femelle, Fièvre (étiologie), France (épidémiologie), Humains, Hôpitaux universitaires (), Indice de gravité médicale, Infections des tissus mous (), Infections des tissus mous (sang), Infections des tissus mous (traitement médicamenteux), Jeune adulte, Lymphoedème (), Mâle, Pronostic, Sujet âgé, Sujet âgé de 80 ans ou plus, Études prospectives.
- MESH :
- diagnostic : Fasciite nécrosante.
- sang : Fasciite nécrosante, Infections des tissus mous.
- traitement médicamenteux : Fasciite nécrosante, Infections des tissus mous.
- usage thérapeutique : Antibactériens.
- épidémiologie : Choc septique, Fasciite nécrosante, France.
- étiologie : Abcès, Choc septique, Fasciite nécrosante, Fièvre.
- Adulte, Adulte d'âge moyen, Bactériémie, Diagnostic précoce, Débridement, Fasciite nécrosante, Femelle, Humains, Hôpitaux universitaires, Indice de gravité médicale, Infections des tissus mous, Jeune adulte, Lymphoedème, Mâle, Pronostic, Sujet âgé, Sujet âgé de 80 ans ou plus, Études prospectives.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- Abscess (etiology), Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents (therapeutic use), Bacteremia (complications), Debridement, Early Diagnosis, Fasciitis, Necrotizing (blood), Fasciitis, Necrotizing (diagnosis), Fasciitis, Necrotizing (drug therapy), Fasciitis, Necrotizing (epidemiology), Fasciitis, Necrotizing (etiology), Fasciitis, Necrotizing (surgery), Female, Fever (etiology), France (epidemiology), Hospitals, University (statistics & numerical data), Humans, Lymphedema (complications), Male, Middle Aged, Prognosis, Prospective Studies, Severity of Illness Index, Shock, Septic (epidemiology), Shock, Septic (etiology), Soft Tissue Infections (blood), Soft Tissue Infections (complications), Soft Tissue Infections (drug therapy), Soft Tissue Infections (surgery), Young Adult.
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents.
- geographic , epidemiology : France.
- blood : Fasciitis, Necrotizing, Soft Tissue Infections.
- complications : Bacteremia, Lymphedema, Soft Tissue Infections.
- diagnosis : Fasciitis, Necrotizing.
- drug therapy : Fasciitis, Necrotizing, Soft Tissue Infections.
- epidemiology : Fasciitis, Necrotizing, Shock, Septic.
- etiology : Abscess, Fasciitis, Necrotizing, Fever, Shock, Septic.
- statistics & numerical data : Hospitals, University.
- surgery : Fasciitis, Necrotizing, Soft Tissue Infections.
- Adult, Aged, Aged, 80 and over, Debridement, Early Diagnosis, Female, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Severity of Illness Index, Young Adult.
Abstract
The LRINEC score was developed in a retrospective study in order to distinguish necrotizing fasciitis from severe soft tissue infections using laboratory data.
DOI: 10.1016/j.annder.2009.12.002
PubMed: 20110062
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002B82
Links to Exploration step
pubmed:20110062Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Prognostic value of the LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis) in soft tissue infections: a prospective study at Clermont-Ferrand University hospital].</title><author><name sortKey="Corbin, V" sort="Corbin, V" uniqKey="Corbin V" first="V" last="Corbin">V. Corbin</name><affiliation wicri:level="1"><nlm:affiliation>Service des maladies infectieuses et tropicales, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France. violainecorbin@yahoo.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service des maladies infectieuses et tropicales, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand</wicri:regionArea></affiliation></author><author><name sortKey="Vidal, M" sort="Vidal, M" uniqKey="Vidal M" first="M" last="Vidal">M. Vidal</name></author><author><name sortKey="Beytout, J" sort="Beytout, J" uniqKey="Beytout J" first="J" last="Beytout">J. Beytout</name></author><author><name sortKey="Laurichesse, H" sort="Laurichesse, H" uniqKey="Laurichesse H" first="H" last="Laurichesse">H. Laurichesse</name></author><author><name sortKey="D Incan, M" sort="D Incan, M" uniqKey="D Incan M" first="M" last="D'Incan">M. D'Incan</name></author><author><name sortKey="Souteyrand, P" sort="Souteyrand, P" uniqKey="Souteyrand P" first="P" last="Souteyrand">P. Souteyrand</name></author><author><name sortKey="Lesens, O" sort="Lesens, O" uniqKey="Lesens O" first="O" last="Lesens">O. Lesens</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20110062</idno><idno type="pmid">20110062</idno><idno type="doi">10.1016/j.annder.2009.12.002</idno><idno type="wicri:Area/PubMed/Corpus">002B82</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B82</idno><idno type="wicri:Area/PubMed/Curation">002B82</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B82</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Prognostic value of the LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis) in soft tissue infections: a prospective study at Clermont-Ferrand University hospital].</title><author><name sortKey="Corbin, V" sort="Corbin, V" uniqKey="Corbin V" first="V" last="Corbin">V. Corbin</name><affiliation wicri:level="1"><nlm:affiliation>Service des maladies infectieuses et tropicales, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France. violainecorbin@yahoo.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service des maladies infectieuses et tropicales, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand</wicri:regionArea></affiliation></author><author><name sortKey="Vidal, M" sort="Vidal, M" uniqKey="Vidal M" first="M" last="Vidal">M. Vidal</name></author><author><name sortKey="Beytout, J" sort="Beytout, J" uniqKey="Beytout J" first="J" last="Beytout">J. Beytout</name></author><author><name sortKey="Laurichesse, H" sort="Laurichesse, H" uniqKey="Laurichesse H" first="H" last="Laurichesse">H. Laurichesse</name></author><author><name sortKey="D Incan, M" sort="D Incan, M" uniqKey="D Incan M" first="M" last="D'Incan">M. D'Incan</name></author><author><name sortKey="Souteyrand, P" sort="Souteyrand, P" uniqKey="Souteyrand P" first="P" last="Souteyrand">P. Souteyrand</name></author><author><name sortKey="Lesens, O" sort="Lesens, O" uniqKey="Lesens O" first="O" last="Lesens">O. Lesens</name></author></analytic><series><title level="j">Annales de dermatologie et de venereologie</title><idno type="ISSN">0151-9638</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abscess (etiology)</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Bacteremia (complications)</term><term>Debridement</term><term>Early Diagnosis</term><term>Fasciitis, Necrotizing (blood)</term><term>Fasciitis, Necrotizing (diagnosis)</term><term>Fasciitis, Necrotizing (drug therapy)</term><term>Fasciitis, Necrotizing (epidemiology)</term><term>Fasciitis, Necrotizing (etiology)</term><term>Fasciitis, Necrotizing (surgery)</term><term>Female</term><term>Fever (etiology)</term><term>France (epidemiology)</term><term>Hospitals, University (statistics & numerical data)</term><term>Humans</term><term>Lymphedema (complications)</term><term>Male</term><term>Middle Aged</term><term>Prognosis</term><term>Prospective Studies</term><term>Severity of Illness Index</term><term>Shock, Septic (epidemiology)</term><term>Shock, Septic (etiology)</term><term>Soft Tissue Infections (blood)</term><term>Soft Tissue Infections (complications)</term><term>Soft Tissue Infections (drug therapy)</term><term>Soft Tissue Infections (surgery)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Abcès (étiologie)</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antibactériens (usage thérapeutique)</term><term>Bactériémie ()</term><term>Choc septique (épidémiologie)</term><term>Choc septique (étiologie)</term><term>Diagnostic précoce</term><term>Débridement</term><term>Fasciite nécrosante ()</term><term>Fasciite nécrosante (diagnostic)</term><term>Fasciite nécrosante (sang)</term><term>Fasciite nécrosante (traitement médicamenteux)</term><term>Fasciite nécrosante (épidémiologie)</term><term>Fasciite nécrosante (étiologie)</term><term>Femelle</term><term>Fièvre (étiologie)</term><term>France (épidémiologie)</term><term>Humains</term><term>Hôpitaux universitaires ()</term><term>Indice de gravité médicale</term><term>Infections des tissus mous ()</term><term>Infections des tissus mous (sang)</term><term>Infections des tissus mous (traitement médicamenteux)</term><term>Jeune adulte</term><term>Lymphoedème ()</term><term>Mâle</term><term>Pronostic</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>France</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Fasciitis, Necrotizing</term><term>Soft Tissue Infections</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Bacteremia</term><term>Lymphedema</term><term>Soft Tissue Infections</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Fasciitis, Necrotizing</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Fasciite nécrosante</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Fasciitis, Necrotizing</term><term>Soft Tissue Infections</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Fasciitis, Necrotizing</term><term>Shock, Septic</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Abscess</term><term>Fasciitis, Necrotizing</term><term>Fever</term><term>Shock, Septic</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Fasciite nécrosante</term><term>Infections des tissus mous</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitals, University</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Fasciitis, Necrotizing</term><term>Soft Tissue Infections</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Fasciite nécrosante</term><term>Infections des tissus mous</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Choc septique</term><term>Fasciite nécrosante</term><term>France</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Abcès</term><term>Choc septique</term><term>Fasciite nécrosante</term><term>Fièvre</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Debridement</term><term>Early Diagnosis</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prognosis</term><term>Prospective Studies</term><term>Severity of Illness Index</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Bactériémie</term><term>Diagnostic précoce</term><term>Débridement</term><term>Fasciite nécrosante</term><term>Femelle</term><term>Humains</term><term>Hôpitaux universitaires</term><term>Indice de gravité médicale</term><term>Infections des tissus mous</term><term>Jeune adulte</term><term>Lymphoedème</term><term>Mâle</term><term>Pronostic</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The LRINEC score was developed in a retrospective study in order to distinguish necrotizing fasciitis from severe soft tissue infections using laboratory data.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20110062</PMID><DateCreated><Year>2010</Year><Month>01</Month><Day>29</Day></DateCreated><DateCompleted><Year>2010</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2010</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0151-9638</ISSN><JournalIssue CitedMedium="Print"><Volume>137</Volume><Issue>1</Issue><PubDate><Year>2010</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Annales de dermatologie et de venereologie</Title><ISOAbbreviation>Ann Dermatol Venereol</ISOAbbreviation></Journal><ArticleTitle>[Prognostic value of the LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis) in soft tissue infections: a prospective study at Clermont-Ferrand University hospital].</ArticleTitle><Pagination><MedlinePgn>5-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.annder.2009.12.002</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The LRINEC score was developed in a retrospective study in order to distinguish necrotizing fasciitis from severe soft tissue infections using laboratory data.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the prognostic value of the LRINEC score in infectious cellulitis.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">A prospective study was performed at the departments of infectious diseases and dermatology of the Clermont-Ferrand University Hospital. The three evaluation criteria were: time from initiation of antibiotics to regression of erythema, duration of fever and occurrence of complications (abscess, surgery, septic shock, necrotizing fasciitis, death, transfer to intensive care). Potential predictive variables were: LRINEC score>6 at admission, comorbidities, local appearance, clinical presentation and soft tissue ultrasound results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty patients were included. The rate of complications was higher for patients with a LRINEC score>6 (54%) than for patients with a score<6 (12%, P=0.008). However, a LRINEC score>6 on admission was not significantly associated with increased duration of erythema or of fever. Prior lymphoedema was associated with a better prognosis.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The LRINEC score may be a useful tool for the detection of complicated forms of soft tissue infections. Patients with a LRINEC score>6 on admission should be carefully evaluated (hospitalization, surgical assessment, close monitoring).</AbstractText><CopyrightInformation>Copyright (c) 2009. Published by Elsevier Masson SAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corbin</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Service des maladies infectieuses et tropicales, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France. violainecorbin@yahoo.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidal</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Beytout</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Laurichesse</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>D'Incan</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Souteyrand</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Lesens</LastName><ForeName>O</ForeName><Initials>O</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Valeur pronostique du score Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) dans les dermohypodermites infectieuses : étude prospective au CHU de Clermont-Ferrand.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2009</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Ann Dermatol Venereol</MedlineTA><NlmUniqueID>7702013</NlmUniqueID><ISSNLinking>0151-9638</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000038" MajorTopicYN="N">Abscess</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016470" MajorTopicYN="N">Bacteremia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003646" MajorTopicYN="N">Debridement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019115" MajorTopicYN="N">Fasciitis, Necrotizing</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018461" MajorTopicYN="N">Soft Tissue Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20110062</ArticleId><ArticleId IdType="pii">S0151-9638(09)00759-5</ArticleId><ArticleId IdType="doi">10.1016/j.annder.2009.12.002</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B82 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002B82 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:20110062
|texte= [Prognostic value of the LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis) in soft tissue infections: a prospective study at Clermont-Ferrand University hospital].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:20110062" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |